Director of Psychology, MedStar National Rehabilitation Network, Washington, DC, USA.
Clinical Neuropsychologist, MedStar Good Samaritan Hospital, Baltimore, MD, USA.
Arch Clin Neuropsychol. 2024 Apr 24;39(3):276-289. doi: 10.1093/arclin/acae017.
The severe acute respiratory syndrome coronavirus 2 virus has, up to the time of this article, resulted in >770 million cases of COVID-19 illness worldwide, and approximately 7 million deaths, including >1.1 million in the United States. Although defined as a respiratory virus, early in the pandemic, it became apparent that considerable numbers of people recovering from COVID-19 illness experienced persistence or new onset of multi-system health problems, including neurologic and cognitive and behavioral health concerns. Persistent multi-system health problems are defined as Post-COVID-19 Condition (PCC), Post-Acute Sequelae of COVID-19, or Long COVID. A significant number of those with PCC report cognitive problems. This paper reviews the current state of scientific knowledge on persisting cognitive symptoms in adults following COVID-19 illness. A brief history is provided of the emergence of concerns about persisting cognitive problems following COVID-19 illness and the definition of PCC. Methodologic factors that complicate clear understanding of PCC are reviewed. The review then examines research on patterns of cognitive impairment that have been found, factors that may contribute to increased risk, behavioral health variables, and interventions being used to ameliorate persisting symptoms. Finally, recommendations are made about ways neuropsychologists can improve the quality of existing research.
截至本文撰写之时,严重急性呼吸综合征冠状病毒 2 型病毒已在全球范围内导致超过 7.7 亿例 COVID-19 疾病,约有 700 万人死亡,其中包括美国的超过 110 万人。尽管它被定义为一种呼吸道病毒,但在大流行早期,就明显看出相当多的 COVID-19 疾病康复者出现了持续或新出现的多系统健康问题,包括神经认知和行为健康问题。持续的多系统健康问题被定义为 COVID-19 后状况 (PCC)、COVID-19 后急性后遗症或长期 COVID。相当多的 PCC 患者报告存在认知问题。本文综述了 COVID-19 疾病后成年人持续存在认知症状的当前科学知识状况。简要介绍了人们对 COVID-19 疾病后持续存在认知问题的关注以及 PCC 的定义的出现。还回顾了使人们难以清楚了解 PCC 的方法学因素。然后,本文研究了已经发现的认知障碍模式、可能导致风险增加的因素、行为健康变量以及用于减轻持续症状的干预措施。最后,就神经心理学家如何提高现有研究质量提出了建议。